A detailed history of First Trust Capital Management L.P. transactions in Surmodics Inc stock. As of the latest transaction made, First Trust Capital Management L.P. holds 16,405 shares of SRDX stock, worth $539,068. This represents 0.1% of its overall portfolio holdings.

Number of Shares
16,405
Previous 17,577 6.67%
Holding current value
$539,068
Previous $681,000 4.7%
% of portfolio
0.1%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$37.5 - $40.13 $43,950 - $47,032
-1,172 Reduced 6.67%
16,405 $649,000
Q3 2024

Nov 14, 2024

BUY
$38.47 - $42.24 $676,187 - $742,452
17,577 New
17,577 $681,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $460M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track First Trust Capital Management L.P. Portfolio

Follow First Trust Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on First Trust Capital Management L.P. with notifications on news.